Large Atrial Septal Defect Closure in a Patient with Severe Pulmonary Arterial Hypertension.
10.5090/kjtcs.2017.50.5.378
- Author:
Supomo SUPOMO
1
;
Anggoro Budi HARTOPO
;
Dyah Wulan ANGGRAHINI
;
Handy DARMAWAN
;
Lucia Kris DINARTI
Author Information
1. Thoracic and Cardiovascular Surgery Division, Dr. Sardjito General Hospital, Universitas Gadjah Mada, Indonesia. supomo.tkv@mail.ugm.ac.id
- Publication Type:Original Article
- Keywords:
Atrial heart septal defects;
Beraprost;
Congenital heart disease;
Pulmonary hypertension;
Sildenafil citrate
- MeSH:
Heart Defects, Congenital;
Heart Septal Defects, Atrial*;
Humans;
Hypertension*;
Hypertension, Pulmonary;
Sildenafil Citrate
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2017;50(5):378-381
- CountryRepublic of Korea
- Language:English
-
Abstract:
Patients with an atrial septal defect (ASD) and severe pulmonary arterial hypertension (PAH) are considered ineligible for defect closure surgery because of the risk of right ventricular decompensation and death after the operation. We report the case of a patient with large ASD and severe PAH who was able to undergo defect closure surgery successfully following long-term use of combined oral sildenafil and beraprost.
